1309 Pilot Service of Community Pharmacist Management of Continuous Glucose Monitors in Patients with Type 2 Diabetes Not on Insulin Therapy

F.G. Penchi; J. Schaefer; S. Veach; M. Witry; T. Bullock

doi:10.1016/j.japh.2025.102769

Objectives The objectives of this project are to: 1. Pilot a pharmacist-led intervention with over-the-counter continuous glucose monitors (CGM) in patients with type 2 diabetes mellitus (T2DM) not on insulin therapy. 2. Assess participant satisfaction and willingness of pharmacist-led service with a post-data collection survey. Background: This is a pilot project of a pharmacist-led service in a rural community with a satisfaction survey upon completion. The rationale behind this pilot service is that some patients with T2DM may have a challenging time reaching their glycemic targets with self-monitoring. Community pharmacists can be pivotal in consulting patients on CGM devices and interpreting results. By implementing a diabetes management service alongside the support of a CGM device, pharmacists can counsel on diet and nutrition in this rural population. Recommendations for the use of CGMs in patients with T2DM who are on insulin are clear, but less is established with patients who are not on insulin. With the recent availability of over-the-counter (OTC) CGMs, this valuable tool, along with education and monitoring, may benefit those with T2DM who are not on insulin in successfully managing their disease and delaying or preventing disease progression. Methods This pilot service will use a semi structured monthly intervention led by a pharmacist. Utilizing the pharmacy dispensing system and electronic health record (EHR), Pioneer, a list of patients with ICD10 codes and health conditions for T2DM was compiled. This list was then filtered for patients not on insulin therapy. Once identified, the participants will be approached in the pharmacy and if interested, orientated on the service. The primary visit will focus on establishing participants' expectations and collecting participants baseline medication list, weight, activity level, and overall diet habits. At this time participants will be orientated on the use of the OTC CGM. Each intervention thereafter the pharmacists will collect CGM information and any changes to the patient’s medication list, activity level and dietary goals. Baseline data will be compared to the data collected at the final intervention. Goals will be set individually with each patient with the focus of maintaining participants' blood glucose within range (70-180 mg/dL) with diet and exercise modifications. Each participant will have a CGM as a tool to better understand how food and exercise affect their glucose levels. At each intervention the pharmacist will conduct a medication reconciliation and notate any changes to the patient's drug regimen. Pharmacists will also use the CGM data to communicate with patients about high or low blood glucose readings. There will be four in person interventions (initial, month 1 follow-up, month 2 follow-up, month 3 follow-up with satisfaction survey) estimated at 15-30 minutes each. At the final intervention in month 4 a satisfaction survey will be provided for the participants. The satisfaction survey will focus on satisfaction with previous self-monitoring and satisfaction with pharmacist assisted service. Analyses will use descriptive statistics to describe participant characteristics, pharmacist interventions, patient plans, and responses to the satisfaction survey. Results Results pending. Conclusions/Implications With the data collected from monthly interventions and the satisfaction survey we expect to assess if this is a viable service to initiate in the pharmacy and potential changes that could be made to improve the service if expanded.

1309 Pilot Service of Community Pharmacist Management of Continuous Glucose Monitors in Patients with Type 2 Diabetes Not on Insulin Therapy

View Online

Abstract

Details

Metrics